Active ingredientNitrazepamCat. No. P-N077-001CAS 146-22-5Family · Pharmaceutical analytical standards
Nitrazepam
A long-acting benzodiazepine, synthesised in Switzerland in the late 1950s, patented in 1961 and in use since 1965: it is used for insomnia and sometimes for certain forms of epilepsy. This family brings together the active ingredient, pharmacopoeial impurities, metabolites and other impurities.
Did you know?The prefix 'nitra-' recalls the nitro group in its structure, which places it among the nitrobenzodiazepines; for research, a light-activated version called fulgazepam has been derived from its molecule.
Go to the active ingredient →Active ingredientNitrazepamCat. No. P-N077-001CAS 146-22-5
Pharmacopoeial impurityNitrazepam EP Impurity ACat. No. P-N077-002CAS 36020-93-6
Pharmacopoeial impurityNitrazepam EP Impurity BCat. No. P-N077-003CAS 1775-95-7
Pharmacopoeial impurityNitrazepam EP Impurity CCat. No. P-N077-004CAS 2011-70-3
Pharmacopoeial impurityNitrazepam EP Impurity DCat. No. P-N077-005CAS 33311-76-1
Metabolite7-AminonitrazepamCat. No. P-N077-006CAS 4928-02-3
ImpurityNitrazepam Impurity 1Cat. No. P-N077-007CAS 20821-91-4No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceNitrazepam CRSEDQM code N0900000Family NitrazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.